Laboratory testing for heritable thrombophilia: impact on clinical management of thrombotic disease

This publication has 16 references indexed in Scilit:

• The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation
  New England Journal of Medicine, 1999
• Hormone replacement therapy
  The Lancet, 1999
• Antiphospholipid antibodies and thrombosis
  The Lancet, 1999
• A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism
  New England Journal of Medicine, 1999
• The Risk of Recurrent Venous Thromboembolism in Carriers and Non-carriers of the G1691A Allele in the Coagulation Factor V Gene and the G20210A Allele in the Prothrombin Gene
  Thrombosis and Haemostasis, 1999
• Guidelines on oral anticoagulation: third edition
  British Journal of Haematology, 1998
• Risk of recurrent venous thromboembolism in patients with the factor V Leiden (FVR506Q) mutation: effect of warfarin and prediction by precipitating factors
  British Journal of Haematology, 1998
• The Long-Term Clinical Course of Acute Deep Venous Thrombosis
  Annals of Internal Medicine, 1996
• Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives
  American Journal of Obstetrics and Gynecology, 1995
• Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect
  The Lancet, 1993